{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:37:44Z","timestamp":1769150264496,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"the European Community\u2019s Seventh Framework Programme","award":["FP7\/2012\u20132017"],"award-info":[{"award-number":["FP7\/2012\u20132017"]}]},{"name":"RiskyCAD","award":["305739"],"award-info":[{"award-number":["305739"]}]},{"DOI":"10.13039\/501100002803","name":"Fondazione CARIPLO","doi-asserted-by":"crossref","award":["2011-0645"],"award-info":[{"award-number":["2011-0645"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MIUR Progetto Eccellenza"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.phrs.2018.12.022","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T02:34:31Z","timestamp":1545791671000},"page":"189-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids"],"prefix":"10.1016","volume":"141","author":[{"given":"Stefano","family":"Manzini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Busnelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Minoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Ossoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Brambilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eftychia","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Persidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Scanziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.12.022_bib0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.52.7.1330","article-title":"A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group","volume":"52","author":"Biton","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.12.022_bib0010","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1212\/WNL.52.9.1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.12.022_bib0015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2018.12.022_bib0020","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.59.5_suppl_2.S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.12.022_bib0025","first-page":"57","article-title":"Antiepileptic drugs: indications other than epilepsy","volume":"6","author":"Spina","year":"2004","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.phrs.2018.12.022_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/WCO.0b013e3283462c3f","article-title":"Treatment of migraine: update on new therapies","volume":"24","author":"Magis","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/2042098612455357","article-title":"Topiramate and cognitive impairment: evidence and clinical implications","volume":"3","author":"Mula","year":"2012","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.phrs.2018.12.022_bib0040","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0149-2918(08)80045-8","article-title":"Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy","volume":"30","author":"Ben-Menachem","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2018.12.022_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clinthera.2005.02.013","article-title":"Topiramate monotherapy in epilepsy and migraine prevention","volume":"27","author":"Silberstein","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.phrs.2018.12.022_bib0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2011.05.014","article-title":"Topiramate-induced weight loss: a review","volume":"95","author":"Verrotti","year":"2011","journal-title":"Epilepsy Res."},{"issue":"Suppl 1","key":"10.1016\/j.phrs.2018.12.022_bib0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2018.12.022_bib0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.amjcard.2005.03.053","article-title":"Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension","volume":"96","author":"Tonstad","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0065","first-page":"35","article-title":"Management of obesity and cardiometabolic risk - role of phentermine\/extended release topiramate","volume":"7","author":"Sweeting","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.phrs.2018.12.022_bib0070","doi-asserted-by":"crossref","first-page":"44503","DOI":"10.1038\/srep44503","article-title":"Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE-\/- mice","volume":"7","author":"Busnelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.12.022_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097598","article-title":"A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice","volume":"9","author":"Parolini","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.12.022_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201700098","article-title":"Effect of dietary components from Antarctic Krill on atherosclerosis in apoE-Deficient mice","volume":"61","author":"Parolini","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phrs.2018.12.022_bib0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.phrs.2018.12.022_bib0090","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003945","article-title":"Characterization of proliferating lesion-resident cells during all stages of atherosclerotic growth","volume":"5","author":"Lhot\u00e1k","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2018.12.022_bib0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.vph.2015.08.006","article-title":"Beta2-adrenergic activity modulates vascular tone regulation in lecithin:cholesterol acyltransferase knockout mice","volume":"74","author":"Manzini","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0100","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.phrs.2018.12.022_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000235993","article-title":"Validation of endogenous internal real-time PCR controls in renal tissues","volume":"30","author":"Cui","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2018.12.022_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/01.ATV.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb. a J. Vasc. Biol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0120","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/hmg\/ddl088","article-title":"Genetic linkage of hyperglycemia, body weight and serum amyloid-P in an intercross between C57BL\/6 and C3H apolipoprotein E-deficient mice","volume":"15","author":"Su","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2018.12.022_bib0125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1475-2840-10-117","article-title":"Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility","volume":"10","author":"Li","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2018.12.022_bib0135","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/01.LAB.0000022222.03120.D4","article-title":"Renal injury in apolipoprotein E-deficient mice","volume":"82","author":"Wen","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phrs.2018.12.022_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1476-511X-13-176","article-title":"Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice","volume":"13","author":"Carneiro","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2018.12.022_bib0145","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s10157-013-0882-9","article-title":"Pathology of glomerular lipidosis","volume":"18","author":"Sato","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2005.10.017","article-title":"Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases","volume":"47","author":"Saito","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.phrs.2018.12.022_bib0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1463-1326.2004.00403.x","article-title":"Topiramate ameliorates hyperglycaemia and improves glucose-stimulated insulin release in ZDF rats and db\/db mice","volume":"7","author":"Liang","year":"2005","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2018.12.022_bib0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/bph.12338","article-title":"The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system","volume":"170","author":"Coomans","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.physbeh.2003.08.013","article-title":"Additive effects of leptin and topiramate in reducing fat deposition in lean and obese ob\/ob mice","volume":"80","author":"Lalonde","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.phrs.2018.12.022_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081963","article-title":"An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-\/-) mice","volume":"8","author":"Vik","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.12.022_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1248\/cpb.c15-00474","article-title":"Ability of Food\/Drink to reduce the bitterness intensity of topiramate as determined by taste sensor analysis","volume":"64","author":"Haraguchi","year":"2016","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.phrs.2018.12.022_bib0180","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/oby.2003.78","article-title":"Predictors of weight loss in adults with topiramate-treated epilepsy","volume":"11","author":"Ben-Menachem","year":"2003","journal-title":"Obes. Res."},{"key":"10.1016\/j.phrs.2018.12.022_bib0185","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1651-2227.2009.01349.x","article-title":"Effects of topiramate on weight and metabolism in children with epilepsy","volume":"98","author":"Li","year":"2009","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.phrs.2018.12.022_bib0190","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.metabol.2006.06.013","article-title":"The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment","volume":"55","author":"Liang","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2018.12.022_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037757","article-title":"Topiramate-induced modulation of hepatic molecular mechanisms: an aspect for its anti-insulin resistant effect","volume":"7","author":"El-Abhar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.12.022_bib0200","doi-asserted-by":"crossref","DOI":"10.1038\/srep28882","article-title":"Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice","volume":"6","author":"Pei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.12.022_bib0205","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1620\/tjem.181.321","article-title":"Abnormal lipid metabolism and renal disorders","volume":"181","author":"Saito","year":"1997","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.phrs.2018.12.022_bib0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0021-9150(90)90025-E","article-title":"Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus","volume":"80","author":"Suzaki","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2018.12.022_bib0215","first-page":"375","article-title":"LCAT deficiency: molecular and phenotypic characterization of an Italian family","volume":"19","author":"Gigante","year":"2006","journal-title":"J. Nephrol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0220","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.12.022_bib0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-1211(97)00045-4","article-title":"Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold","volume":"28","author":"White","year":"1997","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.phrs.2018.12.022_bib0230","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1159\/000358681","article-title":"GABA and topiramate inhibit the formation of human macrophage-derived foam cells by modulating cholesterol-metabolism-associated molecules","volume":"33","author":"Yang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.phrs.2018.12.022_bib0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.mehy.2013.08.029","article-title":"Inhibitory role for GABA in atherosclerosis","volume":"81","author":"Yang","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.phrs.2018.12.022_bib0240","first-page":"245","article-title":"Foam cells and the pathogenesis of kidney disease","volume":"24","author":"Eom","year":"2015","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.phrs.2018.12.022_bib0245","doi-asserted-by":"crossref","first-page":"F339","DOI":"10.1152\/ajprenal.2000.278.3.F339","article-title":"Renal physiology of the mouse","volume":"278","author":"Meneton","year":"2000","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0250","series-title":"Clin. Methods Hist. Phys. Lab. Exam.","first-page":"1087","article-title":"Clinical methods: the history, physical, and laboratory examinations","author":"Walker","year":"1990"},{"key":"10.1016\/j.phrs.2018.12.022_bib0255","series-title":"Harkness and Wagner\u2019s Biology and Medicine of Rabbits and Rodents","first-page":"436","author":"Harkness","year":"1995"},{"key":"10.1016\/j.phrs.2018.12.022_bib0260","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1038\/srep02941","article-title":"Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation","volume":"3","author":"Kesavan","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.12.022_bib0265","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.toxlet.2013.11.014","article-title":"Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis","volume":"224","author":"Stallons","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2018.12.022_bib0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.krcp.2013.01.003","article-title":"Transforming growth factor-beta and the glomerular filtration barrier","volume":"32","author":"Ghayur","year":"2013","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2018.12.022_bib0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cca.2013.06.006","article-title":"Foam cells in atherosclerosis","volume":"424","author":"Yu","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phrs.2018.12.022_bib0280","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12915-017-0392-4","article-title":"Tissue macrophages: heterogeneity and functions","volume":"15","author":"Gordon","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2017.00837","article-title":"The origins and functions of tissue-resident macrophages in kidney development","volume":"8","author":"Munro","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0290","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI97950","article-title":"The role of non-resolving inflammation in atherosclerosis","volume":"128","author":"Kasikara","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.12.022_bib0295","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2018.12.022_bib0300","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MOL.0000000000000279","article-title":"So much cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation","volume":"27","author":"Dubland","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.phrs.2018.12.022_bib0305","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/cvr\/cvy010","article-title":"Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness","volume":"114","author":"Durham","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2018.12.022_bib0310","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ekir.2018.02.005","article-title":"Nephrolithiasis and nephrocalcinosis from topiramate therapy in children with epilepsy","volume":"3","author":"Barnett","year":"2018","journal-title":"Kidney Int. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818313501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818313501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T11:57:49Z","timestamp":1550923069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818313501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":62,"alternative-id":["S1043661818313501"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.12.022","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}